SL
Sentinus LLC Portfolio holdings
AUM
$408M
1-Year Est. Return
12.43%
1 Year Est. Return
+12.43%
AUM
$357M
AUM Growth
+$14.6M
(+4.3%)
Holding
211
Top Buys
| 1 | +$3.55M | |
| 2 | +$3.4M | |
| 3 | +$3.25M | |
| 4 |
Innovator Equity Managed Floor ETF
SFLR
|
+$3.16M |
| 5 |
iShares S&P 100 ETF
OEF
|
+$3.09M |
Top Sells
| 1 | +$3.95M | |
| 2 | +$3.48M | |
| 3 | +$3.26M | |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.44M |
| 5 |
iShares US Infrastructure ETF
IFRA
|
+$1.27M |
Sector Composition
| 1 | Financials | 7.29% |
| 2 | Technology | 4.16% |
| 3 | Healthcare | 2.77% |
| 4 | Communication Services | 1.41% |
| 5 | Consumer Discretionary | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
MasTec
MTZ
$16.7B
| – | – |
-1,529
|
|
||
202
AllianzIM U.S. Large Cap Buffer20 Oct ETF
OCTW
$183M
| – | – |
-5,675
|
|
||
203
SPDR S&P 600 Small Cap Value ETF
SLYV
$4.17B
| – | – |
-7,692
|
|
||
204
iShares 20+ Year Treasury Bond ETF
TLT
$49.5B
| – | – |
-13,468
|
|
||
205
Vanguard Value ETF
VTV
$148B
| – | – |
-4,377
|
|
||
|
NWBO
206
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| – | – |
-12,925
|
|